Clinical Trials Logo

Clinical Trial Summary

This prospective, randomized, single-blinded study is designed to compare the recovery profile between propofol-based total intravenous anesthesia (TIVA) and remimazolam-based TIVA in patients undergoing thyroidectomy. In the remimazolam group, its antagonist, flumazenil, is administered at the end of surgery. We hypothesize that remimazolam-based TIVA antagonized by flumazenil can significantly shorten the time from the end of anesthetic administration to eye-opening compared to propofol-based TIVA.


Clinical Trial Description

Adult patients undergoing elective thyroidectomy are randomly allocated to receive propofol-based TIVA (n=35) or remimazolam-based TIVA (n=35). The recovery profile including the time from the end of anesthetic administration to eye-opening, the time from the end of anesthetic administration to extubation, hemodynamic stability, stability of anesthetic depth, duration of post-anesthetic care stay, the incidence of postoperative nausea and vomiting during the first 24 hours, and the quality of recover 24 hours after surgery using the quality of recovery-15 was assessed by an investigator. The primary outcome is the time from the end of anesthetic administration to eye-opening. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05047939
Study type Interventional
Source Seoul National University Hospital
Contact
Status Completed
Phase N/A
Start date December 14, 2021
Completion date September 11, 2022

See also
  Status Clinical Trial Phase
Completed NCT03861364 - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose. Phase 4
Not yet recruiting NCT06092684 - The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery Phase 3
Not yet recruiting NCT04266535 - TCI vs Manually Controlled Infusion of Propofol
Recruiting NCT03864094 - Hemodynamics During Induction of General Anesthesia After Prophylactic Ephedrine, Phenylephrine or Norepinephrine. Phase 4
Not yet recruiting NCT06237101 - Remifentanil Effect on Burst Suppression Ratio N/A
Completed NCT03861377 - Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses. Phase 4
Completed NCT02492282 - Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System Phase 3
Completed NCT03661489 - Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery Phase 3
Completed NCT02197858 - Comparability of Invasive and Non-invasive Haemodynamic Monitoring N/A
Recruiting NCT03428191 - Target Effect-site Concentration of Remifentanil in Transperineal Prostate Puncture N/A
Completed NCT02527083 - Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain Phase 4
Completed NCT01531491 - Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol N/A
Recruiting NCT00378170 - Laryngoscope Prototype Tested Against the Traditional Macintosh Blade N/A
Completed NCT03614325 - Virtual Reality in the Operating Room N/A
Completed NCT02706431 - Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients N/A
Withdrawn NCT04586998 - Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon" N/A
Active, not recruiting NCT05343260 - Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery N/A
Completed NCT02660411 - Impact of Anesthesia Maintenance Methods on Long-term Survival N/A